Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: Does TACE Have a Future?
Naoyuki Toyota, Takuji Yamagami, Noriaki Matsuura, Naoko Akiyama, Hiromi Miyoshi, Takahiro Sueoka and Kazuo Awai
Transcatheter arterial chemoembolization (TACE) is the interventional technique and mainstay of treatment for unresectable hepatocellular carcinoma (HCC). TACE is indicated mainly for unresectable HCC, cholangiocarcinoma, and hepatic metastases. In this method if used worldwide; however, many regimens, embolic materials, and techniques exist. The clinical results are also controversial. We present the history and the status of TACE for HCC.Total Pages: 99-111 (13)